News

MIT Technology Review21h
Here’s what food and drug regulation might look like under the Trump administration
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...
Science-Based Medicine3dOpinion
Dr. Vinay Prasad is Repeatedly Undermining RCTs. Why?
In 2023 Dr. Vinay Prasad said that scientists who recognized the limitations of randomized-controlled trials (RCTS) were ...
Commentary: Keep FDA moving forward, not backward
The FDA’s accelerated approval pathway plays a vital role, and scrapping it or reversing course on already-approved therapies ...
After Slashing Thousands of Jobs, Trump’s FDA Wants to Use AI to Rapidly Approve New Drugs
AI is slowly permeating all corners of the federal government, including the Food and Drug Administration, where, according ...
BioSpace2d
Makary, Prasad Lay Out Mission for FDA in Journal Kennedy Called ‘Corrupt’
FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...
Fierce Biotech2d
FDA aims for 'rapid or instant' drug reviews, with AI tool initially assessing applications
The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...
Medpage Today on MSN3d
FDA Officials Lay Out Vision for Agency
The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...